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Abstract
Background/Aims: Insulin signaling to podocytes is relevant for the function of the 
glomerulus. Now, we tested the hypothesis that insulin increases the surface expression of 
canonical transient receptor potential canonical type 6 (TRPC6) channels in podocytes by a 
calcineurin-dependent pathway. Methods: We used quantitative RT-PCR, immunoblotting, 
immunofluorescence and fluorescence spectrophotometry in cultured podocytes. Activation 
of Nuclear Factor of Activated T-cells (NFATc1) was measured using a specific calorimetric 
assay. Results: Insulin increased the expression of TRPC6 transcripts and protein in podocytes. 
Insulin increased TRPC6 transcripts in a time and dose-dependent manner. The insulin-induced 
elevation of TRPC6 transcripts was blocked in the presence of tacrolimus, cyclosporine A, and 
NFAT-inhibitor (each p < 0.01 by ANOVA and Bonferroni's multiple comparison test). Transcripts 
of NOX4, another target gene of the calcineurin-NFAT pathway, were affected in a similar 
way. Immunoblotting showed that the administration of 100 nmol/L insulin increased TRPC6-
proteins 2-fold within 48 hours. Insulin increased the activity of NFATc1 in nuclear extracts (p < 
0.001) whereas tacrolimus, cyclosporine A, and NFAT-inhibitor blocked that insulin effect (p < 
0.001; two way ANOVA). Immunofluorescence showed that insulin increased TRPC6-expression 
on the cell surface. Fluorescence-spectrophotometry and manganese quench experiments 
indicated that the increased TRPC6-expression after insulin administration was accompanied 
by an elevated transplasmamembrane cation influx. Insulin-stimulated surface expression of 
TRPC6 as well as transplasmamembrane cation influx could be reduced by pretreatment with 
tacrolimus. Conclusion: Insulin increases the expression of TRPC6 channels in podocytes by 
activation of the calcineurin-dependent pathway.
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IntroductionDiabetic nephropathy is a major cause of chronic kidney disease. Functional podocytes 
are important for the integrity of the glomerular filtration barrier to prevent albuminuria 
which is an early symptom of diabetic nephropathy [1]. As reviewed by Welsh & Coward, the two fundamental cellular changes that occur in diabetes mellitus are a failure of insulin to 
signal to cells and an environment of hyperglycemia [2]. Several recent studies investigated the 
effects of glucose on podocytes [3-7]. A recent study indicated that mice with specific deletion 
of the insulin receptor from their podocytes develop albuminuria together with histological 
features that resemble diabetic nephropathy, but in a normoglycemic environment. These 
studies pointed to some involved insulin signaling pathways in podocytes, e.g. the activation of 
the mitogen-activated protein kinases and phosphatidylinositol-4, 5-bisphosphate 3-kinase pathways [8]. Other groups showed that insulin increases the expression and mobilization 
of large-conductance Ca(2+)-activated K(+) channels as well as transient receptor potential 
canonical (TRPC6) channels in podocytes [9, 10]. Using biotinylation assays, Kim et al. showed 
that insulin increased surface expression of TRPC6 [10]. Kim et al. showed that insulin may 
increase the surface expression of TRPC6 channels in podocytes due to changes of reactive 
oxygen species [10]. Changes of TRPC6 channels have been associated with proteinuric 
diseases [11]. Recently, we showed an increased TRPC6 channel protein expression in 
podocytes from patients with diabetic nephropathy compared to control subjects [12]. 
We also reported that the expression of TRPC6 channels in podocytes can be modified by 
growth factors [12, 13]. These finding supported the view that insulin-dependent changes 
of TRPC6 channels may be involved in the pathogenesis of diabetic nephropathy. However, 
the underlying pathways are only partly known. Since the calcium-calcineurin-nuclear 
factor of activated T cell (NFAT)-pathway has been associated with diabetic nephropathy 
[14, 15], in the present study we investigated the objective that insulin-induced increase 
of TRPC6 in podocytes may be blocked by calcineurin inhibition. We present evidence that 
insulin modulates TRPC6 channels in cultured podocytes. Treatment with insulin increased 
TRPC6 transcrips, increased TRPC6 protein expression and transplasmamembrane cation 
influx into podocytes. Insulin-stimulated surface expression of TRPC6 could be reduced by 
pretreatment with the calcineurin inhibitors, tacrolimus and cyclosporine A as well as by 
NFAT-inhbitor.
Material and Methods
Preparation of cells
Conditionally immortalized human podocytes (podocyte cell line AB 8/13) were used as described 
[12, 16]. The cell preparation procedures had also been described by our group earlier [12, 13]. The 
podocytes were maintained in RPMI 1640 medium without glucose (Gibco, Life Technologies, CA, USA) 
supplemented with 5.6 mmol/L D-glucose, 10 % fetal bovine serum, 100 units/mL penicillin, and 100 µg/
mL streptomycin (Biochrom AG, Berlin, Germany). Podocytes were seeded on plates and were subjected 
to the experimental treatment at subconfluence. Podocytes were exposed to insulin (final concentration, 
100 nmol/L) [10]. Tacrolimus, cyclosporine and NFAT-inhibitor were used at final concentrations of 15 ng/
mL, 500 nmol/L and 1 μmol/L, respectively [17, 18]. TRPC6 knockdown using siRNA was performed as 
reported previously by our group [13].
RNA isolation and reverse transcription
The RNA isolation and reverse transcription procedures had been described by our group earlier 
[12, 13]. Minor modifications were due to different genes, primers or suppliers of reagents or equipment. 
Total RNA was isolated from podocytes using the RNeasy mini kit including RNase-free DNase set (Qiagen, 
Hilden, Germany). Using the Transcriptor first-strand cDNA synthesis kit (Roche Diagnostics, Mannheim, 
Germany), cDNA was synthesized from 2 μg of total RNA using oligo dT (12-18) and 5 U AMV reverse 
transcriptase at 50°C for 60 min, followed by heating to 85°C for 5 min.
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Quantitative real-time reverse transcriptase polymerase chain reactions
Quantitative real-time reverse transcriptase polymerase chain reactions (qRT-PCR) for transient 
receptor potential canonical type 6 (TRPC6), NOX4, and beta-actin were performed using a LightCycler-
FastStart DNA Master SYBR Green I Kit (Roche Diagnostics) and the following primers:
TRPC6 (Reference Sequence (RefSeq) database accession number: NM_004621); forward, 5’GCC AAT 
GAG CAT CTG GAAAT3’; reverse, 5’TGG AGT CAC ATC ATG GGAGA3’;
Beta-actin (NM_001101.3); forward GGA CTT CGA GCA AGA GATGG; reverse AGC ACT GTG TTG GCG 
TACAG.
NADPH oxidase 4 (NM_001143836): forward AAT TTA GAT ACC CAC CCTCC, reverse TCT GTG GAA 
AAT TAG CTTGG.
LightCycler-Fast Start DNA SYBR Green I mix (Roche Diagnostics) and 500 nmol/L of each primer 
were used in a final volume of 20 μL. The reaction was initiated at 95°C for 10 min, followed by 40 cycles 
of denaturation at 95°C for 10 s, annealing for 10 s at at 57°C, and extension at 72°C for 15 s. Melting 
curve analysis was performed from 65°C to 95°C with a heating rate of 0.1°C/s. Data were recorded on 
a LightCycler 2.0 Instrument using LightCycler Software Version 4.0 (Roche Diagnostics). The relative 
quantification method was used whereby the change in expression of target relative to the housekeeping 
gene was calculated. Control PCR was performed from samples containing RNA instead of cDNA.
PCR products were size fractionated on 1% agarose gels, and were visualized by ethidium bromide 
staining using an imaging analyzer (GelDoc 2000; BioRad Laboratories, Munich, Germany). The expected 
product size was 109 bp for TRPC6.
Immunoblotting of proteins
The immunoblottings had been described by our group earlier [12, 13, 19, 20]. Minor modifications 
were due to different proteins, suppliers of reagents or equipment. Protein samples were separated by 10% 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to Hybond-ECL 
nitrocellulose membranes (NEN Life Science, Boston, MA, USA). Membranes were incubated with primary 
antibodies and were subsequently incubated with secondary IRDye800CW-infrared ﬂuorescent dye-labeled 
sheep anti-rabbit antibodies (1:1000, Biomol, Hamburg, Germany) and Alexa Fluor 680-allophyco cyanin-
ﬂuorescence-labeled donkey anti-goat antibodies (1:1000; Invitrogen). Imaging was performed using 
the Odyssey infrared imaging system (Licor Biosciences, Bad Homburg, Germany). Podocytes’ plasma 
membrane proteins were biotinylated and isolated using a commercially available cell surface protein 
isolation kit (Pierce Biotechnology, Rockford, IL, USA) according to the manufacturer’s recommendations. 
The isolated proteins were identified by immunoblotting.
Immunofluorescence
Immunofluorescence had been described by our group earlier [13]. Minor modifications were due 
to different proteins, suppliers of reagents or equipment. Cells were fixed in 3.7% formaldehyde for 20 
min and permeabilized with 0.1% Triton X-100 for 20 min. Samples were then blocked and incubated with 
primary TRPC6 antibodies from rabbit (1:100; Alomone Labs, Jerusalem, Israel) or GAPDH antibodies from 
goat (1:100; Santa Cruz Biotechnology, Inc., USA) overnight at 4°C. Samples were subsequently incubated 
with secondary Alexa Fluor 488-conjugated anti-rabbit antibodies (1:100; Invitrogen, Carlsbad, CA, USA), or 
secondary Alexa Fluor 594-conjugated anti-goat antibodies (Invitrogen). Nuclei were counterstained with 
4', 6-diamidino -2-phenylindole (DAPI; Roche, Mannheim, Germany, 1:1500). For staining of actomyosin 
bundles (stress fibers), cells were fixed in 3.7% formaldehyde for 10 min, permeabilized with 0.2% Triton 
X-100 for 5 min, washed, and incubated in blocking buffer for 30 minutes. Samples were incubated with 
Alexa Fluor 488-conjugated phalloidin antibody (5 ug/mL; Invitrogen) for 30 min, washed and nuclei were 
counterstained with DAPI. Cell images were taken using Floid Cell Imaging Station (Life Technologies, 
Grand Island, NY, USA). Mean values of actomyosin bundles (stress fibers) from 20 areas of interest were determined.
Activation of Nuclear Factor of Activated T-cells (NFAT)
To evaluate the activation of NFAT in podocytes we used Nuclear Extract kit and TransAM NFATC1 
transcription factor assay kit according to the manufacturer’s instructions (Active Motif, Carlsbad, California, 
USA). Briefly, cultured podocytes were harvested, washed, lysed in hypotonic buffer and centrifuged for 
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30 seconds at 14,000 x g in a microcentrifuge. The nuclear fraction was resuspended in complete lysis 
buffer with dithiothreitol, lysis buffer AMI, and protease inhibitor cocktail and centrifuged at 14,000 x g in 
a microcentrifuge. The nuclear extract in complete lysis buffer was added to a microwell plate coated with 
the oligonucleotide 5’-AGGAAA-3’, containing a NFAT consensus binding site, incubated for 1 hour, washed, 
primary NFATc1 antibody was added for 1 hour, washed, and secondary antimouse horseradish peroxidase 
conjugated antibody was added for 1 hour. The absorbance of the calorimetric reaction was measured after 
addition of a development solution and a stopping solution at 450 nm with a reference wavelength of 655 nm.
Measurements of cytosolic calcium using fluorescent dye technique
Measurements of cytosolic calcium using fluorescent dye technique had been described by our group 
earlier [12, 13, 19-21]. Minor modifications were due to different suppliers of reagents or equipment. 
For ratiometric imaging experiments podocytes were loaded with 10 µmol/L of the calcium-sensitive, 
cell-permeable, intracellular fluorescence dye fluo-4 acetoxymethylester (Merck Biosciences, Darmstadt, 
Germany) at room temperature for 1h and then washed with physiological saline solution containing 134 
mmol/L NaCl, 6 mmol/L KCl, 2 mmol/L CaCl
2
, 1 mmol/L MgCl
2
, 10 mmol/L glucose, and 10 mmol/L HEPES 
(pH 7.4 with NaOH) to remove extraneous dye. Fluorescence was measured using a plate reader (Perkin 
Elmer EnSpire Multimode Plate Reader; Denmark) at 515nm emission with 488nm excitation.  Baseline 
fluorescence was measured and stable fluorescence readings were obtained throughout. Calcium influx 
was induced by the known TRPC6 agonist oleoyl-2-acetyl-snglycerol (OAG). The amplitudes were expressed 
as increase of the fluorescence ratio (F/F0). To report unidirectional cation fluxes manganese quenching 
experiments were performed as described by our group [21].
Substances
Tacrolimus (molecular weight, 822 Da), cyclosporine A (molecular weight, 1202 Da), and NFAT-
inhibitor were purchased from Sigma-Aldrich, St. Louis, MO, USA. The NFAT-inhibitor is a high-affinity 
calcineurin-binding peptide that inhibits Nuclear Factor of Activated T cells (NFAT) activation, has the 
amino acid sequence, Met-Ala-Gly-Pro-His-Pro-V al-Ile-Val-Ile-Thr-Gly-Pr o-His-Glu-Glu, and has a molecular 
weight of 1683 Da. All substances were obtained from Sigma-Aldrich (St. Louis, MO, USA) if not indicated otherwise.
Statistical Analysis
All data were expressed as mean ± SD. Comparisons between groups were analyzed using the t-test 
or ANOVA and Bonferroni's multiple comparison test as appropriate. The variation of NFATc1 activity in 
nuclear extracts caused by insulin and calcineurin inhibitors and NFAT-inhibitor was determined using 
two-way ANOVA (GraphPad Prism 5.0, La Jolla, CA, USA). A two-tailed probability value less than 0.05 was 
considered statistically significant. Where error bars do not appear on the figure, error was within the symbol size.
Results
Figure 1 shows the effect of insulin on TRPC6 transcripts in podocytes. Using 
quantitative real time RT-PCR, we detected TRPC6 transcripts in podocytes. Compared to 
control conditions the administration of insulin for 15 minutes increased TRPC6 transcripts 
by 3.2 ± 0.3 fold (p < 0.01). Increased TRPC6 transcript levels could be observed for up to 
48 hours (Fig. 1A). The dose-dependent effect of insulin on TRPC6 transcripts is shown in 
Fig. 1B. We investigated the effects of calcineurin inhibitors, tacrolimus and cyclosporine A, 
and the NFAT-inhibitor (Fig. 1C). In the presence of tacrolimus, cyclosporine A, and NFAT-
inhibitor the insulin-induced elevation of TRPC6 transcripts was blocked to 1.1 ± 0.2, 0.9 ± 
0.2, and 0.8 ± 0.2, respectively (each p < 0.01 by ANOVA and Bonferroni's multiple comparison 
test). According to literature, NOX4 may be another target gene of the calcineurin-NFAT 
pathway [10]. Compared to control conditions the administration of insulin increased NOX4 
transcripts by 1.7 ± 0.5 fold (p < 0.05), whereas addition of tacrolimus, cyclosporine A, 
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and NFAT-inhibitor blocked the insulin-induced elevation of NOX4 transcripts to 1.1 ± 0.2, 
1.1 ± 0.3, and 1.1 ± 0.1, respectively (each p < 0.05 by ANOVA and Bonferroni's multiple 
comparison test; Fig. 1D).
Next, we established that the administration of 100 nmol/L insulin increased TRPC6-
proteins in podocytes. Immunoblotting showed that insulin increased TRPC6 protein 2.2 
± 0.1 fold within 48 hours (Fig. 2A). In the presence of tacrolimus, the insulin-induced 
elevation of TRPC6 proteins was blocked to 1.3±0.1 (p<0.01 by ANOVA and Bonferroni's 
multiple comparison test; Fig. 2B).
After activation, calcineurin binds and dephosphorylates cytoplasmic NFAT, which then 
translocates to the nucleus of activated cells to induce expression of several genes. It is well 
known that tacrolimus, cyclosporine A, as well as selective inhibitors of NFAT-calcineurin-
association, block downstream NFAT effectors [22]. Using a specific calorimetric assay we 
showed that insulin activated the activity of NFATc1 in nuclear extracts from podocytes 
(Fig. 3A). Two-way ANOVA showed that insulin accounted for 40% of the observed total 
variation activity of NFATc1 activity in nuclear extracts (p < 0.001). Furthermore, tacrolimus, 
Fig. 1. Insulin increases transient receptor potential channels type 6 (TRPC6) transcripts in podocytes. (A) 
Quantitative real-time RT-PCR showing the time-dependent effect of insulin on TRPC6 transcripts. Mean ± 
SD are given for the normalized ratio of TRPC6 expression compared to ß-actin. (B) Dose-response curve 
of the effects of insulin on TRPC6 transcripts. Gel electrophoresis of PCR products from TRPC6 transcripts 
after administration of increasing doses of insulin is shown. ß-Actin is shown for comparison. (C) Summary 
data of quantitative real-time RT-PCR for TRPC6 transcripts. *** p < 0.001 for the comparison insulin (Ins) 
and control (Ctrl). ** p < 0.01 for the comparison Ins vs insulin + tacrolimus (Ins + Tac), insulin + cyclospo-
rine A (Ins + CsA), and insulin + NFAT-inhibitor (Ins + NFAT-Inhib), respectively (ANOVA and Bonferroni's 
multiple comparison test). (D) Summary data of quantitative real-time RT-PCR for NOX4 transcripts. * p 
< 0.05 for the comparison insulin (Ins) and control (Ctrl), Ins vs insulin + tacrolimus (Ins + Tac), insulin + 
cyclosporine A (Ins + CsA), and insulin + NFAT-inhibitor (Ins + NFAT-Inhib), respectively (ANOVA and Bon-
ferroni's multiple comparison test).
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cyclosporine A, and NFAT-inhibitor accounted for 42% of the observed total variation of the 
activity of NFATc1 in nuclear extracts (p < 0.001; Fig. 3A).
Immunofluorescence indicated that insulin mainly increased TRPC6-expression on the 
cell surface. This insulin-induced TRPC6 surface expression was blocked in the presence 
of tacrolimus, cyclosporine A, or NFAT-inhibitor (Fig. 3B). Morphology may be variable, 
however, no large morphological changes were observed.
Plasma membrane biotinylation assays showed that the administration of insulin 
increased the expression of TRPC6 in the plasma membrane (Fig. 3C and D).
Manganese quenching experiments indicated that an increased TRPC6-expression 
on the cell surface was accompanied by an increased transplasmamembrane cation influx 
into podocytes (Fig. 3E). Furthermore, the administration of insulin elevated the oleoyl-
2-acetyl-snglycerol (OAG)-induced calcium increase by 22% (Fig. 3F and G). The elevated 
TRPC6-mediated cation influx was reduced after tacrolimus. It should be noted that OAG is 
not specific for activation of the TRPC6 isoform, therefore activation of other isoforms may 
contribute to the observed effects.
To clarify the effects of insulin on TRPC6 expression we used siRNA for TRPC6 knockdown 
in podocytes. Compared to control conditions with scramble RNA the administration of 
siRNA caused a reduction of TRPC6 transcripts to 32 ± 5% (Fig. 4A). Immunofluorescence 
showed that siRNA against TRPC6 reduced insulin-induced TRPC6-expression on the 
cell surface (Fig. 4B). We showed that insulin increased the activity of NFATc1 in nuclear 
extracts from podocytes from 0.25 ± 0.01 to 0.44 ± 0.03 arbitrary units (p < 0.01), whereas 
after administration of siRNA against TRPC6 the activity of NFATc1 was reduced to 0.31 ± 
0.03 arbitrary units (p < 0.01 by ANOVA and Bonferroni's multiple comparison test; Fig. 
4C). Furthermore, both tacrolimus as well as siRNA against TRPC6 attenuated the insulin-
induced expression of stress-fibers in podocytes (Fig. 4D and E). These results underscore 
that the insulin-induced expression of TRPC6 channels in podocytes further enhances the 
calcium-calcineurin-NFAT pathway.
Fig. 2. Insulin increases transient receptor potential channels type 6 (TRPC6) protein in podocytes. (A) 
Representative immunoblottings (top panels) and summary data of TRPC6 protein in podocytes after ad-
ministration of insulin. Data are mean ± SD, ** p < 0.01 compared to control conditions by ANOVA and Bon-
ferroni's multiple comparison test. (B) Representative immunoblottings and summary data (bar graphs) of 
TRPC6 protein under control conditions (Control) and in the presence of insulin (Ins), tacrolimus (Tac) or 
both, insulin plus tacrolimus (Ins + Tac). ** p < 0.01 compared to control conditions by ANOVA and Bonfer-
roni's multiple comparison test.
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Fig. 3. Insulin acti-
vates NFAT in podo-cytes and increases 
TRPC6 protein local-ized in the plasma 
membrane. (A) Sum-
mary data of a specific calorimetric assay of 
NFATc1 in nuclear ex-tracts from podocytes. 
Insulin accounted 
for 40% (p < 0.001), 
whereas tacrolimus, 
cyclosporine A, and 
NFAT-inhibitor ac-
counted for 42% of 
the observed total 
variation of the ac-
tivity of NFATc1 in 
nuclear extracts (p 
< 0.001). (B) Repre-
sentative immuno-
fluorescence of TRPC6 protein under control 
conditions (Ctrl) and in the presence of in-
sulin (Ins), tacrolimus 
(Tac), insulin + tacro-
limus (Ins + Tac), in-
sulin + cyclosporine 
A (Ins + CsA), and in-
sulin + NFAT-inhibitor 
(Ins + Inhib). Scale 
bar = 10 µm. Immuno-
fluorescence data may only be interpreted 
semi-quantitatively. 
(C) Plasma membrane biotinylation assays of plasma membrane and intracellular 
TRPC6 expression. (D) 
The ratios of plasma membrane to intracel-
lular TRPC6 were summarized (n = 3 in each group; * p < 0.05 between indicated groups by ANOVA with 
Bonferroni's multiple comparison test. (E) Representative manganese quenching experiments showing 
oleoyl-2-acetyl-snglycerol (OAG)-induced and TRPC6-mediated electrolyte influx into podocytes. Fluores-
cence values are shown after stimulation with OAG under control conditions (Control) and in the presence 
of insulin (Ins), tacrolimus (Tac) or both, insulin plus tacrolimus (Ins + Tac). Representative fluorescence 
measurements (F) and summary data (G) of oleoyl-2-acetyl-snglycerol (OAG)-induced and TRPC6-mediated 
calcium increase in podocytes. The F/F0 ratio is given after stimulation with OAG under control conditions 
(Control) and in the presence of insulin (Ins), tacrolimus (Tac) or both, insulin plus tacrolimus (Ins + Tac). 
* p < 0.05.
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Discussion
The main finding of our present study is that insulin increases the expression of TRPC6 
channels in podocytes by activation of the calcineurin-dependent pathway. We observed 
that insulin increased TRPC6 transcripts, TRPC6 proteins, TRPC6 localized in the plasma 
membrane of podocytes, as well as transplasmamembrane cation influx.
Several investigations showed that TRPC6 plays an important role in podocyte function. 
The upregulation of TRPC6 has been associated with acquired proteinuric kidney diseases 
[23], whereas TRPC6-deficient mice have been reported to be resistant to angiotensin II-
induced proteinuria [24]. Furthermore our group reported increased TRPC6 channel protein 
in podocytes from patients with diabetic nephropathy compared to control subjects [12].
We showed increased TRPC6 transcripts for up to 48 hours after activation. Others 
also showed that the activation of podocytes increases TRPC6 transcripts within 12 to 24 
hours [25]. An increased TRPC6 expression may activate the calcium-calmodulin-dependent 
serine/threonine protein phosphatase, calcineurin, which dephosphorylates nuclear factor 
of activated T cells which then subsequently translocates to the cell nucleus. Earlier studies 
indicated that activation of this calcium-calmodulin-dependent calcineurin-nuclear factor 
of activated T cells-pathway causes podocytes damage [26]. In cardiac cells TRPC6 has been 
described as a positive regulator of calcium-calcineurin-nuclear factor of activated T-cells-
signaling during pathologic cardiac remodeling [27]. The present study in podocytes showed 
Fig. 4. siRNA against TRPC6 modulates 
insulin-dependent NFATc1 activity and 
podocyte activation. (A) Effect of siRNA 
on TRPC6 transcripts. Ctrl indicates 
scramble RNA. (B) Representative im-
munofluorescence of insulin-induced 
TRPC6 protein in podocytes under con-
trol conditions (Ctrl)) and after admin-
istration of siRNA against TRPC6 (siR-
NA). (C) Bar graph of NFATc1 activity in nuclear extracts from podocytes under 
control conditions (Ctrl), in the presence 
of siRNA against TRPC6 (siRNA), after 
administration of insulin (Ins), and af-
ter administration of both siRNA against 
TRPC6 and insulin (Ins + siRNA). ** p < 
0.01 between indicated groups (ANOVA 
and Bonferroni's multiple comparison 
test). (D) Expression of stress-fibers in podocytes after stimulation with insulin 
for 24 hours in the absence and presence 
of tacrolimus and siRNA against TRPC6. 
(E) Summary data of stress fiber analy-
ses which were performed in 20 areas 
of interest for each condition. The coef-
ficient of variation was 11%, 10%, 9%, 
and 21% for Ctrl, Ins, Ins + Tac, and Ins 
+ siRNA, respectively. *** p < 0.001 for the comparison between the indicated 
groups by ANOVA and Bonferroni's mul-tiple comparison test.
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that siRNA against TRPC6 reduced NFATc1 activity, indicating that the insulin-induced 
expression of TRPC6 channels in podocytes further enhances the calcium-calcineurin-NFAT 
pathway probably by a positive regulation loop. In podocytes, Nijenhuis et al. reported that 
the angiotensin-II-induced TRPC6 expression required the activation of the calcineurin as 
well as the nuclear factor of activated T cells [28]. It should be noted that other substances, 
i.e. angiotensin-II, which stimulate podocytes also activated the calcium-calcineurin-
NFAT pathway [28]. They also showed that a podocyte-specific inducible expression of a 
constitutively active NFAT cells-mutant increased TRPC6 expression and induced severe 
proteinuria [28]. Schlöndorff et al. described that TRPC6 mutations which enhance channel 
activity caused an enhanced basal nuclear factor of activated T cells-mediated transcription 
in podocytes [29]. In support of these findings, Liu et al. showed that the administration of the 
calcineurin inhibitor, tacrolimus, reduced enhanced glomerular TRPC6 protein expressions 
in adriamycin-treated rats [30].Our present study now indicated that inhibition of calcineurin blocks the insulin-
induced expression of TRPC6 channels in podocytes. Our results are in line with previous 
studies, showing that the inhibition of calcineurin reduced renal hypertrophy and blocked 
glomerular hypertrophy in kidneys from diabetic rats [31]. In addition, whole kidney and 
glomerular hypertrophy were also reduced in diabetic calcineurin A-β knockout mice [32]. 
It may be concluded that the insulin-TRPC6-calcium/calmodulin-calcineurin-nuclear factor 
of activated T cells-pathway may be important for the pathogenesis of diabetic nephropathy. 
In summary, we show that insulin increased the expression of TRPC6 channels in podocytes by a calcineurin-dependent pathway.
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